GlaxoSmithKline’s ‘serial disappointments’ cast doubt on its growth plans: analyst

GlaxoSmithKline’s ‘serial disappointments’ cast doubt on its growth plans: analyst
arlene.weintraub
Thu, 01/21/2021 – 10:55